HERC2 as a Potential Biomarker for Prognosis and Response to Bevacizumab in Ovarian Cancer: A Bioinformatics Approach

Articles > Article · 2025

Authors: FATİH YAY, HASAN ÇAĞRI YILDIRIM

Reproductive Sciences, Journal Indexed in SCI Expanded, International, WoS, 2025, vol 32, pp 3567-3586

DOI: 10.1007/s43032-025-01977-6

View details